Transitional versus surgical menopause in a rodent model

Etiology of ovarian hormone loss impacts memory and the acetylcholine system

Jazmin I. Acosta, Loretta Mayer, Joshua S. Talboom, Candy Wing S Tsang, Constance J Smith, Craig K. Enders, Heather A. Bimonte-Nelson

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

Clinical research suggests that type of ovarian hormone loss at menopause influences cognition. Until recently ovariectomy (OVX) has been the primary rodent model to examine effects of ovarian hormone loss on cognition. This model limits evaluations to abrupt and complete ovarian hormone loss, modeling less than 13% of women who receive surgical menopause. The majority of women do not have their ovaries surgically removed and undergo transitional hormone loss via ovarian follicular depletion. 4-Vinylcyclohexene-diepoxide (VCD) produces gradual ovarian follicular depletion in the rodent, with hormone profiles more similar to naturally menopausal women vs. OVX. We directly compared VCD and OVX models to examine whether type of hormone loss (transitional vs. surgical) impacted cognition as assessed on a maze battery as well as the cholinergic system tested via scopolamine mnemonic challenge and brain acetylcholinesterase activity. Middle-aged rats received either sham surgery, OVX surgery, VCD, or VCD then OVX to assess effects of removal of residual ovarian output after transitional menopause and follicular depletion. VCD-induced transitional menopause impaired learning of a spatial recent memory task; surgical removal of residual ovarian hormones by OVX abolished this negative effect of transitional menopause. Furthermore, transitional menopause before OVX was better for memory than an abrupt loss of hormones via OVX only. Surgical ovarian hormone loss, regardless of menopause history, increased hippocampal acetylcholinesterase activity. Circulating gonadotropin and androstenedione levels were related to cognitive competence. Collectively, findings suggest that in the rat, initiation of transitional menopause before surgical ovary removal can benefit mnemonic function and could obviate some negative cognitive consequences of surgical menopause alone.

Original languageEnglish (US)
Pages (from-to)4248-4259
Number of pages12
JournalEndocrinology
Volume150
Issue number9
DOIs
StatePublished - Sep 2009

Fingerprint

Memory Disorders
Menopause
Acetylcholine
Rodentia
Hormones
Cognition
Acetylcholinesterase
Ovary
Scopolamine Hydrobromide
Androstenedione
Ovariectomy
Gonadotropins
Mental Competency
Cholinergic Agents
4-vinyl-1-cyclohexene dioxide
Learning
Brain

ASJC Scopus subject areas

  • Endocrinology

Cite this

Transitional versus surgical menopause in a rodent model : Etiology of ovarian hormone loss impacts memory and the acetylcholine system. / Acosta, Jazmin I.; Mayer, Loretta; Talboom, Joshua S.; Tsang, Candy Wing S; Smith, Constance J; Enders, Craig K.; Bimonte-Nelson, Heather A.

In: Endocrinology, Vol. 150, No. 9, 09.2009, p. 4248-4259.

Research output: Contribution to journalArticle

Acosta, Jazmin I. ; Mayer, Loretta ; Talboom, Joshua S. ; Tsang, Candy Wing S ; Smith, Constance J ; Enders, Craig K. ; Bimonte-Nelson, Heather A. / Transitional versus surgical menopause in a rodent model : Etiology of ovarian hormone loss impacts memory and the acetylcholine system. In: Endocrinology. 2009 ; Vol. 150, No. 9. pp. 4248-4259.
@article{08cc2ee9e8f9465ea28bd4fde2a4662b,
title = "Transitional versus surgical menopause in a rodent model: Etiology of ovarian hormone loss impacts memory and the acetylcholine system",
abstract = "Clinical research suggests that type of ovarian hormone loss at menopause influences cognition. Until recently ovariectomy (OVX) has been the primary rodent model to examine effects of ovarian hormone loss on cognition. This model limits evaluations to abrupt and complete ovarian hormone loss, modeling less than 13{\%} of women who receive surgical menopause. The majority of women do not have their ovaries surgically removed and undergo transitional hormone loss via ovarian follicular depletion. 4-Vinylcyclohexene-diepoxide (VCD) produces gradual ovarian follicular depletion in the rodent, with hormone profiles more similar to naturally menopausal women vs. OVX. We directly compared VCD and OVX models to examine whether type of hormone loss (transitional vs. surgical) impacted cognition as assessed on a maze battery as well as the cholinergic system tested via scopolamine mnemonic challenge and brain acetylcholinesterase activity. Middle-aged rats received either sham surgery, OVX surgery, VCD, or VCD then OVX to assess effects of removal of residual ovarian output after transitional menopause and follicular depletion. VCD-induced transitional menopause impaired learning of a spatial recent memory task; surgical removal of residual ovarian hormones by OVX abolished this negative effect of transitional menopause. Furthermore, transitional menopause before OVX was better for memory than an abrupt loss of hormones via OVX only. Surgical ovarian hormone loss, regardless of menopause history, increased hippocampal acetylcholinesterase activity. Circulating gonadotropin and androstenedione levels were related to cognitive competence. Collectively, findings suggest that in the rat, initiation of transitional menopause before surgical ovary removal can benefit mnemonic function and could obviate some negative cognitive consequences of surgical menopause alone.",
author = "Acosta, {Jazmin I.} and Loretta Mayer and Talboom, {Joshua S.} and Tsang, {Candy Wing S} and Smith, {Constance J} and Enders, {Craig K.} and Bimonte-Nelson, {Heather A.}",
year = "2009",
month = "9",
doi = "10.1210/en.2008-1802",
language = "English (US)",
volume = "150",
pages = "4248--4259",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "9",

}

TY - JOUR

T1 - Transitional versus surgical menopause in a rodent model

T2 - Etiology of ovarian hormone loss impacts memory and the acetylcholine system

AU - Acosta, Jazmin I.

AU - Mayer, Loretta

AU - Talboom, Joshua S.

AU - Tsang, Candy Wing S

AU - Smith, Constance J

AU - Enders, Craig K.

AU - Bimonte-Nelson, Heather A.

PY - 2009/9

Y1 - 2009/9

N2 - Clinical research suggests that type of ovarian hormone loss at menopause influences cognition. Until recently ovariectomy (OVX) has been the primary rodent model to examine effects of ovarian hormone loss on cognition. This model limits evaluations to abrupt and complete ovarian hormone loss, modeling less than 13% of women who receive surgical menopause. The majority of women do not have their ovaries surgically removed and undergo transitional hormone loss via ovarian follicular depletion. 4-Vinylcyclohexene-diepoxide (VCD) produces gradual ovarian follicular depletion in the rodent, with hormone profiles more similar to naturally menopausal women vs. OVX. We directly compared VCD and OVX models to examine whether type of hormone loss (transitional vs. surgical) impacted cognition as assessed on a maze battery as well as the cholinergic system tested via scopolamine mnemonic challenge and brain acetylcholinesterase activity. Middle-aged rats received either sham surgery, OVX surgery, VCD, or VCD then OVX to assess effects of removal of residual ovarian output after transitional menopause and follicular depletion. VCD-induced transitional menopause impaired learning of a spatial recent memory task; surgical removal of residual ovarian hormones by OVX abolished this negative effect of transitional menopause. Furthermore, transitional menopause before OVX was better for memory than an abrupt loss of hormones via OVX only. Surgical ovarian hormone loss, regardless of menopause history, increased hippocampal acetylcholinesterase activity. Circulating gonadotropin and androstenedione levels were related to cognitive competence. Collectively, findings suggest that in the rat, initiation of transitional menopause before surgical ovary removal can benefit mnemonic function and could obviate some negative cognitive consequences of surgical menopause alone.

AB - Clinical research suggests that type of ovarian hormone loss at menopause influences cognition. Until recently ovariectomy (OVX) has been the primary rodent model to examine effects of ovarian hormone loss on cognition. This model limits evaluations to abrupt and complete ovarian hormone loss, modeling less than 13% of women who receive surgical menopause. The majority of women do not have their ovaries surgically removed and undergo transitional hormone loss via ovarian follicular depletion. 4-Vinylcyclohexene-diepoxide (VCD) produces gradual ovarian follicular depletion in the rodent, with hormone profiles more similar to naturally menopausal women vs. OVX. We directly compared VCD and OVX models to examine whether type of hormone loss (transitional vs. surgical) impacted cognition as assessed on a maze battery as well as the cholinergic system tested via scopolamine mnemonic challenge and brain acetylcholinesterase activity. Middle-aged rats received either sham surgery, OVX surgery, VCD, or VCD then OVX to assess effects of removal of residual ovarian output after transitional menopause and follicular depletion. VCD-induced transitional menopause impaired learning of a spatial recent memory task; surgical removal of residual ovarian hormones by OVX abolished this negative effect of transitional menopause. Furthermore, transitional menopause before OVX was better for memory than an abrupt loss of hormones via OVX only. Surgical ovarian hormone loss, regardless of menopause history, increased hippocampal acetylcholinesterase activity. Circulating gonadotropin and androstenedione levels were related to cognitive competence. Collectively, findings suggest that in the rat, initiation of transitional menopause before surgical ovary removal can benefit mnemonic function and could obviate some negative cognitive consequences of surgical menopause alone.

UR - http://www.scopus.com/inward/record.url?scp=69249121724&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=69249121724&partnerID=8YFLogxK

U2 - 10.1210/en.2008-1802

DO - 10.1210/en.2008-1802

M3 - Article

VL - 150

SP - 4248

EP - 4259

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 9

ER -